Shkreli plans to remain silent at congressional hearing -letter

NEW YORK, Jan 21 (Reuters) - Former drug executive Martin Shkreli plans to assert his right against self-incrimination and remain silent if he is forced to appear at a congressional hearing in Washington next week about drug prices, according to a letter seen by Reuters.